Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.

Nikolai Klebanov Vartan PahalyantsWilliam S MurphyNicholas TheodosakisLeyre ZubiriR Monina KlevensShawn G KwatraEvelyn LillyKerry Lynn Reynolds Yevgeniy R Semenov

Published in: The oncologist (2021)

ICIs did not increase the rate of COVID-19. This information may assist patients and their oncologists in decision-making surrounding cancer treatment during this pandemic.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
decision making
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
healthcare
respiratory syndrome coronavirus
palliative care
social media